The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Laura Forker,Piers Gaunt,Stefano Sioletic,Patrick Shenjere,Robert Potter,Darren L. Roberts,Joely J Irlam,Helen R Valentine,David Hughes,Ana Hughes,Lucinda Billingham,Rob Grimer,Beatrice Seddon,Ananya Choudhury,Martin Robinson,Catharine M L West

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

2018

Laura Forker
Piers Gaunt
Stefano Sioletic
Patrick Shenjere
Robert Potter
Darren L. Roberts
Joely J Irlam
Helen R Valentine
David Hughes
Ana Hughes
Lucinda Billingham
Rob Grimer
Beatrice Seddon
Ananya Choudhury
Martin Robinson
Catharine M L West

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Keywords:

Medicine
Pathology
Immunology
Cohort
Soft tissue sarcoma
Biobank
Biomarker (medicine)
Sarcoma
Hypoxia (medical)
Gene signature
Tumour heterogeneity
Metastasis
Tissue microarray
Hazard ratio
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations